1-7 of 7
Kelli Cole
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Post-Transplant Cyclophosphamide, Abatacept and Short Course of Tacrolimus (CAST) for Graft-Versus-Host Disease Prevention Following Haploidentical Peripheral Blood Stem Cell Transplantation

A Samer Al-Homsi, Frank Cirrone, Kelli Cole, Jaime Andres Suarez-Londono, Sharon L. Gardner, Jingmei Hsu, Stephanie Wo, Kelsey Stocker, Benedetto Bruno, Judith Goldberg, Benjamin Levinson, Maher Abdul-Hay
Journal: Blood
Blood (2022) 140 (Supplement 1): 7628–7630.
https://doi.org/10.1182/blood-2022-162634
Published: 2022
Journal Articles

Post-Transplant High Dose Cyclophosphamide and Bortezomib As Graft-Versus-Host Disease Prophylaxis Following Allogeneic Hematopoietic Stem Cell Transplantation

Benedetto Bruno, Frank Cirrone, Kelli Cole, Kelsey Stocker, Maher Abdul-Hay, J Andres Suarez-Londono, Tsivia Hochman, Judith Goldberg, A Samer Samer Al-Homsi
Journal: Blood
Blood (2021) 138 (Supplement 1): 3892.
https://doi.org/10.1182/blood-2021-151809
Published: 2021
Journal Articles

Post-Transplant Cyclophosphamide, Abatacept, and Short Course of Tacrolimus Combination (CAST) Is Safe and Seems Highly Effective in Preventing Graft-Versus-Host Disease Following Haploidentical Peripheral Blood Stem Cell Transplantation

A Samer Samer Al-Homsi, Frank Cirrone, Kelli Cole, Kelsey Stocker, Benedetto Bruno, J Andres Suarez-Londono, Judith Goldberg, Maher Abdul-Hay
Journal: Blood
Blood (2021) 138 (Supplement 1): 3906.
https://doi.org/10.1182/blood-2021-150856
Published: 2021
Journal Articles

Post-Transplant Cyclophosphamide Overcomes Graft-Versus-Host Disease Aggravation Induced By Extended Administration of Proteasome Inhibitors

A. Samer Al-Homsi, MD, Austin Goodyke, Kelli Cole, MSN, Marlee Muilenburg, BSN, Michael McLane, Sarah Abdel-Mageed, Muneer H. Abidi, MD, Stephanie F. Williams, MD
Journal: Blood
Blood (2016) 128 (22): 4543.
https://doi.org/10.1182/blood.V128.22.4543.4543
Published: 2016
Journal Articles

Bendamustine, Carfilzomib, and Melphalan (BCM) Conditioning Prior to Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: A Feasibility Study

A. Samer Al-Homsi, MD, Marlee Muilenburg, BSN, Kelli Cole, MSN, Muneer H. Abidi, MD, Stephanie F. Williams, MD
Journal: Blood
Blood (2016) 128 (22): 4635.
https://doi.org/10.1182/blood.V128.22.4635.4635
Published: 2016
Journal Articles

Ixazomib Impairs Dendritic Cell Function and T Cell Proliferation and Affects the Development of GvHD in a Schedule-Dependent Fashion

Yuxin Feng, PhD, Austin Goodyke, Marlee Muilenberg, BSN, RN, Kelli Cole, MSN, RN, Kathleen Cannady, DVM, Anding Shen, PhD, A. Samer Al-Homsi, MD
Journal: Blood
Blood (2015) 126 (23): 1881.
https://doi.org/10.1182/blood.V126.23.1881.1881
Published: 2015
Journal Articles

Post-Transplant Cyclophosphamide and Bortezomib Combination for Prevention of GvHD after Allogeneic Blood and Marrow Transplantation Is Feasible and Produces Favorable Outcomes

A. Samer Al-Homsi, MD, Tara S Roy, NP, Kelli Cole, RN, MSN, Marlee Bogema, RN, BSN, Stephanie F Williams, MD, Ulrich A. Duffner, MD, Aly Mageed, MD
Journal: Blood
Blood (2014) 124 (21): 3920.
https://doi.org/10.1182/blood.V124.21.3920.3920
Published: 2014